EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Estrogen Receptors: A New Frontier in Alzheimer’s Disease Therapy

Giovanni Luca Cipriano iD, Emanuela Mazzon, Ivan Anchesi

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25169077 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Giovanni Luca Cipriano und 2 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Centro Neurolesi "Bonino-Pulejo", Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy. Hauptthemen laut MEDLINE: Alzheimer Disease, Receptors, Estrogen. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, Ministry of Health, Italy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is a long-term neurodegenerative condition that leads to the deterioration of neurons and synapses in the cerebral cortex, resulting in severe dementia. AD is significantly more prevalent in postmenopausal women, suggesting a neuroprotective role for estrogen. Estrogen is now known to regulate a wide array of physiological functions in the body by interacting with three known estrogen receptors (ERs) and with the β-amyloid precursor protein, a key factor in AD pathogenesis. Recent experimental evidence indicates that new selective ER modulators and phytoestrogens may be promising treatments for AD for their neuroprotective and anti-apoptotic properties. These alternatives may offer fewer side effects compared to traditional hormone therapies, which are associated with risks such as cardiovascular diseases, cancer, and metabolic dysfunctions. This review sheds light on estrogen-based treatments that may help to partially prevent or control the neurodegenerative processes characteristic of AD, paving the way for further investigation in the development of estrogen-based treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseReceptors, EstrogenHumansAnimalsEstrogensNeuroprotective AgentsPhytoestrogensAmyloid beta-Protein PrecursorSelective Estrogen Receptor Modulators

Stichwörter der Autor:innen

Alzheimer’s diseaseestrogen receptorsestrogen signalingneurodegenerative diseases

Substanzen

Receptors, EstrogenEstrogensNeuroprotective AgentsPhytoestrogensAmyloid beta-Protein PrecursorSelective Estrogen Receptor Modulators

Autor:innen und Institutionen

  • IRCCS Centro Neurolesi "Bonino-Pulejo", Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy.

ORCID-Profile: Giovanni Luca Cipriano

Förderung

  • Ministero della Salute
  • Ministry of Health, Italy

Zitieren

APA

Cipriano, G. L., Mazzon, E., & Anchesi, I. (2024). Estrogen Receptors: A New Frontier in Alzheimer’s Disease Therapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25169077

Vancouver

Cipriano GL, Mazzon E, Anchesi I. Estrogen Receptors: A New Frontier in Alzheimer’s Disease Therapy. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25169077

BibTeX
@article{Cipriano2024,
  author = {Cipriano, Giovanni Luca and Mazzon, Emanuela and Anchesi, Ivan},
  title = {Estrogen Receptors: A New Frontier in Alzheimer’s Disease Therapy},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25169077}
}
Kostenlos starten →